Genomic Profiling Identifies Outcome-Relevant Mechanisms of Innate and Acquired Resistance to Third-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Lung Cancer With ...
New data analysis clarifies misleading benchmarks released by a competitor; separate SkylineDx analysis demonstrates Merlin CP-GEP Test provides stronger metastatic-risk stratification and superior ...
Data from Second Independent Multi-Center Study of Patients with High-Risk Cutaneous Squamous Cell Carcinoma Confirms Independent Risk-Stratification Performance of DecisionDx®-SCC ...
Study reveals how Cytovale's IntelliSep® sepsis test enables early sepsis risk stratification and more precise documentation, increasing SEP-1 compliance by 29% SAN FRANCISCO and SALT LAKE CITY, Sept.
Meditech is working with population health management company Arcadia Healthcare Solutions, which will help integrate new data into its web-based electronic health record. Both companies said the ...
(L) Giles Robinson, MD, St. Jude Division of Neuro-oncology director, Department of Oncology, co-corresponding author on the Neuro-Oncology and Cancer Research studies and (R) Xin Zhou, PhD, St. Jude ...
New, combined validation cohort of 1,412 patients with high-risk squamous cell carcinoma (SCC) demonstrates that the addition of DecisionDx-SCC to Brigham & Women's Hospital (BWH) staging ...
Castle Biosciences will present TissueCypher Barrett’s Esophagus test data at DDW 2025, emphasizing risk stratification and personalized patient management. Castle Biosciences, Inc. will present new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback